The Snail Signaling Branch Downstream of the TGF-β/Smad3 Pathway Mediates Rho Activation and Subsequent Stress Fiber Formation
Overview
Affiliations
Cancer cells acquire malignant phenotypes through an epithelial-mesenchymal transition, which is induced by environmental factors or extracellular signaling molecules, including transforming growth factor-β (TGF-β). Among epithelial-mesenchymal transition-associated cell responses, cell morphological changes and cell motility are closely associated with remodeling of the actin stress fibers. Here, we examined the TGF-β signaling pathways leading to these cell responses. Through knockdown experiments in A549 lung adenocarcinoma cells, we found that Smad3-mediated induction of Snail, but not that of Slug, is indispensable for morphological changes, stress fiber formation, and enhanced motility in cells stimulated with TGF-β. Ectopic expression of Snail in SMAD3-knockout cells rescued the defect in morphological changes and stress fiber formation by TGF-β, indicating that the role of Smad3 in these responses is to upregulate Snail expression. Mechanistically, Snail is required for TGF-β-induced upregulation of Wnt5b, which in turn activates RhoA and subsequent stress fiber formation in cooperation with phosphoinositide 3-kinase. However, ectopic expression of Snail in SMAD3-knockout cells failed to rescue the defect in cell motility enhancement by TGF-β, indicating that activation of the Smad3/Snail/Wnt5b axis is indispensable but not sufficient for enhancing cell motility; a Smad3-dependent but Snail-independent pathway to activate Rac1 is additionally required. Therefore, the Smad3-dependent pathway leading to enhanced cell motility has two branches: a Snail-dependent branch to activate RhoA and a Snail-independent branch to activate Rac1. Coordinated activation of these branches, together with activation of non-Smad signaling pathways, mediates enhanced cell motility induced by TGF-β.
TGF-β2 enhances nanoscale cortex stiffness via condensation of cytoskeleton-focal adhesion plaque.
Duan M, Liu Y, Pi C, Zhao Y, Tian Y, Xie J Biophys J. 2024; 124(2):336-350.
PMID: 39645584 PMC: 11788479. DOI: 10.1016/j.bpj.2024.12.007.
Epithelial-mesenchymal plasticity in cancer: signaling pathways and therapeutic targets.
Wang X, Xue X, Pang M, Yu L, Qian J, Li X MedComm (2020). 2024; 5(8):e659.
PMID: 39092293 PMC: 11292400. DOI: 10.1002/mco2.659.
Cross-Talk between the TGF-β and Cell Adhesion Signaling Pathways in Cancer.
Liao J, Chen R, Lin B, Deng R, Liang Y, Zeng J Int J Med Sci. 2024; 21(7):1307-1320.
PMID: 38818471 PMC: 11134594. DOI: 10.7150/ijms.96274.